Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...
Bucknell University1d
Kate Ellis '25 Makes a Selfless Donation to Save a Life
Kate Ellis '25 took time away from classes to prioritize the needs of a leukemia patient she had never met, making a ...
ALZFORUM14d
Sex Differences in Blood of Alzheimer’s and Parkinson’s Patients
Sex Delta by Cell Type. In men with Alzheimer’s (top left), B cells (red boxes) were fewer (blue), while NK cells (blue boxes ...
Physician's Weekly1d
Haploidentical Transplants with Low-Dose ATG and PTCy Improve Outcomes in Older Patients
The following is a summary of “Improved survival in older patients with myeloid malignancies undergoing haploidentical ...
Revelation Biosciences: Gemini priming attenuates inflammatory response in PBMCs
Revelation Biosciences (REVB) announced Gemini priming attenuates the inflammatory response in human peripheral blood mononuclear cells exposed ...
AHA/ASA Journals8d
Myeloid Fatty Acid Metabolism Activates Neighboring Hematopoietic Stem Cells to Promote Heart Failure With Preserved Ejection Fraction
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
CURE2d
Darzalex Plus Revlimid Improves Outcomes in Newly Diagnosed Myeloma
Darzalex and Revlimid maintenance resulted in superior outcomes versus Revlimid alone following autologous stem cell ...
Morningstar4d
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
announced Gemini priming attenuates the inflammatory response in human peripheral blood mononuclear cells (PBMCs) exposed to clinically relevant promoter molecules of inflammation. Revelation ...